NDC 51655-008 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC51655-008

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Northwind Health Company, LLC
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA078152
Marketed since
August 8, 2022
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (2)

Package NDCDescriptionSince
51655-008-2020 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-008-20)Oct 31, 2022
51655-008-5310 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-008-53)Aug 8, 2022

Other Ondansetron products